“…The foremost use of 1,5 Benzothiazepine clinically approved was Diltiazem, followed by Clentiazem for Cardio protective agent (Zhang et al, 2010). Few of 1,5-benzothiazepine derivatives were also clinically ruled for CNS disorders like Thiazesim and Quetiapine fumarate (Takada et al, 2012). 1,5-benzothiazepine moiety is a favored group of pharmacophore, as compounds bearing this structural unit possess a broad spectrum of biological activities such as anticancer (Prasad et al, 2018), antimicrobial, V2 arginine vasopressin receptor antagonist, anti arrhythmic, Hypolipidemic, Bradykinin agonist, vasodilator, Anticholinesterase inhibitor, anticonvulsant, HIV-1 reverse transcriptase inhibitor, Glycogen synthase kinase-3β inhibitor, Ca+2 Channel blocking, antiangina, anti HIV and Squalene synthetase inhibitor so on (Raghavendra et al, 2015).…”